Cargando…

Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort

RATIONALE: Some COPD patients develop extreme breathlessness, decreased exercise capacity and poor health status yet respiratory disability is poorly characterized as a distinct phenotype. OBJECTIVE: To define respiratory disability in COPD based on available functional measures and to determine ass...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cooper, Christopher B, Paine, Robert, Curtis, Jeffrey L, Kanner, Richard E, Martinez, Carlos H, Meldrum, Catherine A, Bowler, Russell, O’Neal, Wanda, Hoffman, Eric A, Couper, David, Quibrera, Miguel, Criner, Gerald, Dransfield, Mark T, Han, MeiLan K, Hansel, Nadia N, Krishnan, Jerry A, Lazarus, Stephen C, Peters, Stephen P, Barr, R Graham, Martinez, Fernando J, Woodruff, Prescott G
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7417644/ https://www.ncbi.nlm.nih.gov/pubmed/32821092 http://dx.doi.org/10.2147/COPD.S250191

Ejemplares similares

Frequency of Exacerbations in COPD: An Analysis of the SPIROMICS Cohort
por: Han, MeiLan K., et al.
Publicado: (2017)

Lower serum IgA is associated with COPD exacerbation risk in SPIROMICS
por: Putcha, Nirupama, et al.
Publicado: (2018)

Clinical Significance of Bronchodilator Responsiveness Evaluated by Forced Vital Capacity in COPD: SPIROMICS Cohort Analysis
por: Barjaktarevic, Igor Z, et al.
Publicado: (2019)

Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort
por: Opron, Kristopher, et al.
Publicado: (2021)

Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study
por: Labaki, Wassim W., et al.
Publicado: (2019)

Sputum or blood eosinophil association with clinical measures of COPD severity in the SPIROMICS cohort
por: Hastie, AT, et al.
Publicado: (2017)

Design of the Subpopulations and Intermediate Outcome Measures in COPD (SPIROMICS) AIR Study
por: Hansel, Nadia N, et al.
Publicado: (2017)

Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS
por: Zhang, William Z., et al.
Publicado: (2020)

Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort
por: Zhang, William Z., et al.
Publicado: (2021)

Defining Chronic Mucus Hypersecretion Using the CAT in the SPIROMICS Cohort
por: Stott-Miller, Marni, et al.
Publicado: (2020)

Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts
por: Fawzy, Ashraf, et al.
Publicado: (2018)

Longitudinal Imaging-Based Clusters in Former Smokers of the COPD Cohort Associate with Clinical Characteristics: The SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Zou, Chunrui, et al.
Publicado: (2021)

Imaging-based clusters in former smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and intermediate outcome measures in COPD study (SPIROMICS)
por: Haghighi, Babak, et al.
Publicado: (2019)

Imaging-based clusters in current smokers of the COPD cohort associate with clinical characteristics: the SubPopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Haghighi, Babak, et al.
Publicado: (2018)

Black carbon content in airway macrophages is associated with increased severe exacerbations and worse COPD morbidity in SPIROMICS
por: Tejwani, Vickram, et al.
Publicado: (2022)

Comparison of serum, EDTA plasma and P100 plasma for luminex-based biomarker multiplex assays in patients with chronic obstructive pulmonary disease in the SPIROMICS study
por: O’Neal, Wanda K, et al.
Publicado: (2014)

Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort
por: Bhatt, Surya P., et al.
Publicado: (2018)

The matrikine acetyl-proline-glycine-proline and clinical features of COPD: findings from SPIROMICS
por: Wells, J. Michael, et al.
Publicado: (2019)

The influence of social support on COPD outcomes mediated by depression
por: Turnier, Leonard, et al.
Publicado: (2021)

Design of a multi-center immunophenotyping analysis of peripheral blood, sputum and bronchoalveolar lavage fluid in the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS)
por: Freeman, Christine M, et al.
Publicado: (2015)

Correcting Nonpathological Variation in Longitudinal Parametric Response Maps of CT Scans in COPD Subjects: SPIROMICS
por: Fernández-Baldera, Antonio, et al.
Publicado: (2017)

Robust Measures of Image-Registration-Derived Lung Biomechanics in SPIROMICS
por: Pan, Yue, et al.
Publicado: (2022)

Latent traits of lung tissue patterns in former smokers derived by dual channel deep learning in computed tomography images
por: Li, Frank, et al.
Publicado: (2021)

Variability in objective and subjective measures affects baseline values in studies of patients with COPD
por: Anderson, Wayne H., et al.
Publicado: (2017)

Genome-wide association study of lung function and clinical implication in heavy smokers
por: Li, Xingnan, et al.
Publicado: (2018)

Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV(1) decline: results from COPDGene and SPIROMICS
por: Wang, Jennifer M., et al.
Publicado: (2023)

Mannose-binding lectin deficiency and acute exacerbations of chronic obstructive pulmonary disease
por: Albert, Richard K, et al.
Publicado: (2012)

Current smoking with or without chronic bronchitis is independently associated with goblet cell hyperplasia in healthy smokers and COPD subjects
por: Kim, Victor, et al.
Publicado: (2020)

A blood and bronchoalveolar lavage protein signature of rapid FEV(1) decline in smoking-associated COPD
por: DiLillo, Katarina M., et al.
Publicado: (2023)

Differentiation of quantitative CT imaging phenotypes in asthma versus COPD
por: Choi, Sanghun, et al.
Publicado: (2017)

Heterogeneous burden of lung disease in smokers with borderline airflow obstruction
por: Pirozzi, Cheryl S., et al.
Publicado: (2018)

Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD
por: Sun, Wei, et al.
Publicado: (2016)

The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model
por: Sadatsafavi, Mohsen, et al.
Publicado: (2016)

Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori
por: Ra, Seung Won, et al.
Publicado: (2017)

Epigenetic marker of telomeric age is associated with exacerbations and hospitalizations in chronic obstructive pulmonary disease
por: Hernández Cordero, Ana I., et al.
Publicado: (2021)

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
por: Duffy, Sean, et al.
Publicado: (2017)

Serum IgG subclass levels and risk of exacerbations and hospitalizations in patients with COPD
por: Leitao Filho, Fernando Sergio, et al.
Publicado: (2018)

An airway epithelial IL-17A response signature identifies a steroid-unresponsive COPD patient subgroup
por: Christenson, Stephanie A., et al.
Publicado: (2018)

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol
por: Bhatt, Surya P, et al.
Publicado: (2016)

The effect of exacerbation history on outcomes in the IMPACT trial
por: Halpin, David M.G., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d9j0s9tuu6d5mqjs1vh8n5f9f9